Randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma [2] (multiple letters)

American Journal of Ophthalmology

Volumn 136, Issue 1, 2003, Pages 217-218

  Eisenberg, Dan ^a   Noecker, Robert J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; LATANOPROST;

ANALYSIS OF VARIANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LETTER; MEDICAL LITERATURE; MULTIVARIATE ANALYSIS OF COVARIANCE; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; THEORETICAL STUDY; TREATMENT OUTCOME;

EID: 0038015616     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00195-8     Document Type: Letter

References (5)

1. The European Agency for the Evaluation of Medicinal Products (EMEA). Committee for proprietary medicinal products (CPMP). Points to consider on switching between superiority and non-inferiority. Available at: http://www.emea.eu.int/pdfs/human/ewp/048299en.pdf. Accessed July 27, 2000
2. M. Suzuki H.K. Mishima K. Masuda M. Araie Y. Kitazawa I. Azuma Efficacy and safety of latanoprost eye drops for glaucoma treatment a 1-year study in Japan Jpn J Ophthalmol 44 2000 33 38
3. T. Aung P.T.K. Chew C.-C. Yip A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension Am J Ophthalmol 131 2001 636 642
4. C.B. Camras Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group Ophthalmology 103 1996 138 147
5. W.J. Scherer A retrospective review of non-responders to latanoprost J Ocular Pharmacol Therapeut 18 2002 287 291